Page last updated: 2024-12-08

pichtosin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pichtosin: contains mainly isobornyl acetate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID637531
CHEMBL ID3183823
MeSH IDM0057553

Synonyms (37)

Synonym
acetic acid, isobornyl ester
ai3-02940
2-camphanyl acetate, exo-
fema no. 2160
isobornyl ethanoate
2-bornyl acetate, exo-
nsc 62486
einecs 204-727-6
exo-1,7,7-trimethylbicyclo(2.2.1)hept-2-yl acetate
bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, acetate, (1r,2r,4r)-rel-
1,7,7-trimethylbicyclo(2.2.1)heptan-2-yl acetate, exo-
isobomyl acetate
pichtosin
nsc-62486
isoborneol, acetate
isobornyl acetate
pichtosine
125-12-2
54t6ccu09z ,
unii-54t6ccu09z
ec 204-727-6
hsdb 8452
bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1r,2r,4r)-rel-
isobornyl acetate [who-dd]
isobornyl acetate [fhfi]
(+/-)-isobornyl acetate
isobornyl acetate [inci]
isobornyl acetate [fcc]
CHEMBL3183823
AKOS028109483
17283-45-3
bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, acetate, (1r,2r,4r)-rel-
Q425010
1,7,7-trimethyl-, acetate, exo-(+-)-bicyclo[2.2.1]heptan-2-ol
[(1r,2r,4r)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl] acetate
BS-42106
AC-35043

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Increased incidences of excess salivation occurred in P generation male and female rats at 100 and/or 300 mg/kg/d throughout the dosage period, and low incidences of urine-stained abdominal fur were seen in females at 300 mg/kg/d during the gestation period."( Oral 1-Generation Rat Reproduction Study of Isobornyl Acetate: An Evaluation Through Sexual Maturity in the F1 Generation.
Api, AM; Diener, RM; Hoberman, AM; Lewis, EM; Patel, A; Politano, VT,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]